Talk:Sanofi

Manual of Style

Jerryseinfeld, please consult Wikipedia:Manual of Style before editing.

• Place external link in the External Links section. Consult Wikipedia:Don't use external links where we'll want Wikipedia links.
• Do not make links if words are linked previously. Consult Wikipedia:Manual of Style.

--JamesTseng 20:45, Nov 13, 2004 (UTC)

• I removed the double link on L'Oreal, are you satisfied? - Jerryseinfeld 22:35, 13 Nov 2004 (UTC)

• To clarify, please place external links such as SNY in External Links section.
• Also, please do not make double link, such as Paris and France in History section. They have been linked in the introduction already.

--JamesTseng 06:06, Nov 14, 2004 (UTC)

• Okay, I give up. - Jerryseinfeld 14:31, 14 Nov 2004 (UTC)

---

Stockholders

The information provided about Stockholders is excellent! I'm just linking the common terms to their proper accounting terms. No intent to discredit the original contributor! --JM Robert 23:55, Nov 25, 2004 (UTC)

Vandalism?

This was pretty funny, 80.177.155.23 writes "Deleted "and Europe's #1 pharma company" - GSK is both European-headquartered and bigger both by revenues & market capitalisation" then JM Robert writes "Rv to JM Robert edit. Vandalism by 80.177.155.23". In reality the company is europe's 3rd largest, and the worlds ?th largest. - Jerryseinfeld 03:09, 4 Dec 2004 (UTC)

December, 2004 (revenue from fiscal year 2003)

• Sanofi-Aventis
  • Revenue: 10118.00 M
  • Market cap: 55.65B
• GlaxoSmithKline
  • Revenue: 38238.00 M
  • Market cap: 127.23B
• AstraZeneca
  • Revenue: 18849.00 M
  • Market cap: 68.19B
• Pfizer
  • Revenue: 45188.00 M
  • Market cap: 210.04B

---

• According to Sanofi-Aventis figures, it is no. 1 in Europe and no. 3 worldwide in pharmaceutical industry. Perhaps it's counting only certain revenues, since many companies are diversified. I think the claim of world's no. 3 is verified by this USA Today article, this Forbes article, this Reuters article. We'll keep the world claim and remove the Europe claim. How is that? --JM Robert 05:36, Dec 4, 2004 (UTC)

• • "Perhaps it's counting only certain revenues". That sounds probable in that case. But what revenues? Just drugs? The "pharmaceutical companies" category has all the drug companies from both Major Drugs and Biotechnology & Drugs. In the Biotech category it's number two by market cap behind Amgen. - Jerryseinfeld 15:09, 4 Dec 2004 (UTC)

I realize I'm joining in late here, but I can't figure out how Johnson & Johnson is smaller than Sanofi-Aventis. J&J is obviously a more spread out company, but according to the List of pharmaceutical companies page here at Wikipedia, pretty much all spending and revenues from their pharm. branch place them higher than Aventis, and obviously J&J is a far bigger company with all things considered. I don't know if this applies to other pharmaceutical companies, but still... in every form I can think of, this places Johnson & Johnson ahead of Sanofi-Aventis, along with Pfizer and GlaxoSmithkline. - David DIBattiste 04:46, 28 December 2006 (UTC)

I've changed the header to call Sanofi-Aventis a company among the largest pharm companies in the world. All the data I see for this argument that supported placing them in a position is two years out of date or more, and I can find no information supporting them holding that position, if they ever did, now. I don't doubt that they are large, hence leaving in the statement, but the way it is worded now is much less contestable and much more likely to remain the case - which is probably important for an article that may not be read often such as this one. David DiBattiste 15:20, 4 January 2007 (UTC)

Other Name

found this: Elf Sanofi, a French pharmaceutical company that signed a joint-venture agreement with the Kodak unit in 1991. Elf Sanofi, a unit of Alf Aquitaine...[1]Gaviidae 17:49, 9 July 2006 (UTC)